WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 11, 2016, Pages 3109-3116

  Jacobsson, Susanne ^a   Golparian, Daniel ^a   Cole, Michelle ^b   Spiteri, Gianfranco ^c   Martin, Irene ^d   Bergheim, Thea ^e   Borrego, Maria José ^f   Crowley, Brendan ^g   Crucitti, Tania ^h   Van Dam, Alje P ⁱ   Hoffmann, Steen ^j   Jeverica, Samo ^k   Kohl, Peter ^l   Mlynarczyk Bonikowska, Beata ^m   Pakarna, Gatis ⁿ   Stary, Angelika ^o   Stefanelli, Paola ^p   Pavlik, Peter ^q   Tzelepi, Eva ^r   Abad, Raquel ^s   Harris, Simon R ^t   Unemo, Magnus ^a   more..

^a ÖREBRO UNIVERSITY   (Sweden)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^g ST JAMES S HOSPITAL   (Ireland)

^h INSTITUTE OF TROPICAL MEDICINE   (Belgium)

ⁱ DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^j STATENS SERUM INSTITUT   (Denmark)

^k UNIVERSITY OF LJUBLJANA   (Slovenia)

^l VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^m MEDICAL UNIVERSITY OF WARSAW   (Poland)

ⁿ Infectology Centre of Latvia   (Latvia)

^o Outpatients' Centre for Infectious Venereodermatological Diseases   (Austria)

^p ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^q HPL spol s ro   (Slovakia)

^r HELLENIC PASTEUR INSTITUTE   (Greece)

^s INSTITUTO DE SALUD CARLOS III   (Spain)

^t WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; MACROLIDE; RNA 23S; SPECTINOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; RIBOSOME DNA;

ADOLESCENT; ADULT; AGED; ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLADISTICS; ESCHERICHIA COLI; EUROPE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MTRR GENE; NEISSERIA GONORRHOEAE; NONHUMAN; PHYLOGENOMICS; PROMOTER REGION; RPLD GENE; RPLV GENE; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; GENOTYPE; GONORRHEA; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLUSTER ANALYSIS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; EUROPE; FEMALE; GENES, BACTERIAL; GENOME, BACTERIAL; GENOTYPE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; NEISSERIA GONORRHOEAE; PHYLOGENY; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84994520359     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw279     Document Type: Article

References (44)

1. Newman LM, Rowley J, Vander Hoorn S et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One 2015; 10: e0143304.
2. WHO. Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae. 2012. http://whqlibdoc.who.int/publications/2012/9789241503501_eng.pdf?ua=1.
3. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 2014; 27: 587-613.
4. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 (RR-03): 1-137.
5. Bignell C, Unemo M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 2013; 24: 85-92.
6. Australasian Sexual Health Alliance (ASHA). Australian STI Management Guidelines for Use in Primary Care. www.sti.guidelines.org.au/sexuallytransmissible-infections/gonorrhoea#management.
7. Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections. Gonococcal Infections Chapter. 2013. www. phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/assets/pdf/section-5-6-eng.pdf.
8. Ison CA, Deal C, Unemo M. Current and future treatment options for gonorrhoea. Sex Transm Infect 2013; 89 Suppl 4: iv52-6.
9. Unemo M. Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 2015; 15: 364.
10. Tanaka M, Furuya R, Irie S et al. High prevalence of azithromycinresistant Neisseria gonorrhoeae isolates with a multidrug resistance phenotype in Fukuoka, Japan. Sex Transm Dis 2015; 42: 337-41.
11. ECDC. ECDC Surveillance Report. Gonococcal Antimicrobial Susceptibility Surveillance in Europe 2013. http://ecdc.europa.eu/en/publications/Publications/gonococcal-antimicrobial-susceptibility-surveillance-europe-2013.pdf.
12. Lahra MM; Australian Gonococcal Surveillance Programme. Australian Gonococcal Surveillance Programme annual report, 2014. Commun Dis Intell Q Rep 2015; 39: E347-54.
13. Demczuk W, Martin I, Peterson S et al. Genomic epidemiology and molecular resistance mechanisms of azithromycin resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J Clin Microbiol 2016; 54: 1304-13.
14. Cole MJ, Spiteri G, Jacobsson S et al. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance. BMC Infect Dis 2015; 15: 321.
15. Galarza PG, Alcalá B, Salcedo C et al. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. Sex Transm Dis 2009; 36: 787-8.
16. Palmer HM, Young H, Winter A et al. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J Antimicrob Chemother 2008; 62: 490-4.
17. Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother 2010; 54: 3812-6.
18. Lynagh Y, MacAogáin M,Walsh A et al. Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland. J Antimicrob Chemother 2015; 70: 2411-3.
19. Starnino S, Stefanelli P. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemother 2009; 63: 1200-4.
20. Unemo M, Golparian D, Hellmark B. First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea? Antimicrob Agents Chemother 2014; 58: 624-5.
21. Katz AR, Komeya AY, Soge OO et al. Neisseria gonorrhoeae with highlevel resistance to azithromycin: case report of the first isolate identified in the United States. Clin Infect Dis 2012; 54: 841-3.
22. Allen VG, Seah C, Martin I et al. Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada. Antimicrob Agents Chemother 2014; 58: 2528-34.
23. Yuan LF, Yin YP, Dai XQ et al. Resistance to azithromycin of Neisseria gonorrhoeae isolates from2 cities in China. Sex TransmDis 2011; 38: 764-8.
24. Stevens K, Zaia A, Tawil S et al. Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Australia. J Antimicrob Chemother 2014; 70: 1267-8.
25. Chisholm SA, Wilson J, Alexander S et al. An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England. Sex Transm Infect 2015: doi:10.1136/sextrans-2015-052312.
26. Unemo M, Dillon JA. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin Microbiol Rev 2011; 24: 447-58.
27. Unemo M, Fasth O, Fredlund H et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63: 1142-51.
28. Li H, Handsaker B, Wysoker A et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078-9.
29. Harris SR, Feil EJ, Holden MT et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469-74.
30. Stamatakis A, Ludwig T, Meier H. RAxML-III: a fast programformaximum likelihood-based inference of large phylogenetic trees. Bioinformatics 2005; 21: 456-63.
31. Croucher NJ, Page AJ, Connor TR et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 2015; 43: e15.
32. Pommier T, Canbäck B, Lundberg P et al. RAMI: a tool for identification and characterization of phylogenetic clusters in microbial communities. Bioinformatics 2009; 25: 736-42.
33. Shannon CE. A mathematical theory of communication. Bell System Technical 1948; 27: 379-423.
34. CLC bio. White Paper on CLC Read Mapper. http://www.clcbio.com/files/whitepapers/whitepaper-on-CLC-read-mapper.pdf.
35. Altshuler D, Pollara VJ, Cowles CR et al. An SNP map of the human genome generated by reduced representation shotgun sequencing. Nature 2000; 407: 513-6.
36. Chisholm SA, Unemo M, Quaye N et al. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill 2013; 18: pii=20358.
37. Allen VG, Farrell DJ, Rebbapragada A et al. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob Agents Chemother 2011; 55: 703-12.
38. Cousin SL Jr, Whittington WL, Roberts MC. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. J Antimicrob Chemother 2003; 51: 131-3.
39. Roberts MC, Chung WO, Roe D et al. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob Agents Chemother 1999; 43: 1367-72.
40. Unemo M, Nicholas RA, Jerse AE et al. Molecular mechanisms of antibiotic resistance expressed by the pathogenic Neisseria (Chapter 9). In: Davies JK, Kahler CM, eds. Pathogenic Neisseria: Genomics, Molecular Biology and Disease Intervention. London, UK: Caister Academic Press, 2014.
41. Ohneck EA, Zalucki YM, Johnson PJ et al. A novel mechanism of highlevel, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. MBio 2011; 2: e00187-11.
42. Ng LK, Martin I, Liu G et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 3020-5.
43. Galarza PG, Abad R, Canigia LF et al. New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2010; 54: 1652-3.
44. Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45.